DNA-Based Zika Vaccine Shows Protection Against Infection

Share this content:
DNA-Based Zika Vaccine Shows Protection Against Infection
DNA-Based Zika Vaccine Shows Protection Against Infection

THURSDAY, Nov. 10, 2016 (HealthDay News) -- An experimental Zika vaccine shows promise, according to research published online Nov. 10 in npj Vaccines.

In animals infected with Zika virus, the synthetic DNA-based vaccine was 100 percent effective in protecting against infection, brain damage, and death, the researchers found. They observed robust antigen-specific antibody and T-cell responses that neutralized the virus.

The vaccine is being tested in two human clinical trials, with results from one study expected to be reported by year's end, the study authors noted.

"Our results support the critical importance of immune responses for both preventing infection as well as ameliorating disease caused by the Zika virus," lead author David Weiner, Ph.D., executive vice president and director of the Vaccine Center at The Wistar Institute in Philadelphia, said in an institute news release. "As the threat of Zika continues, these results provide insight into a new aspect of the possibly protective ability of such a vaccine as a preventative approach for Zika infection."

Weiner disclosed funding from Inovio Pharmaceuticals and GeneOne Life Science.

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »